Abstract
BackgroundAdoptive cellular transfer (ACT) of autologous tumor-infiltrating lymphocytes (TIL) is capable of inducing durable clinical responses in patients with advanced solid malignancies,1 however response rates are low. Limitations in personalized...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
